Applicable QIs were calculated for all patients on the basis of QI criteria (either ER/PR+ or –, HER2+ or –, tumor size ≤ or > 3 cm for invasive tumors and ≤ or > 2 cm for noninvasive tumors, staging of tumor, and other related factors). This evidence concerns the gene PGR and neoplasm.